Active polyarticular Juvenile idiopathic arthritis

Also known as: Active Polyarticular Juvenile Idiopathic Arthritis (pJIA)

Drug	Drug Name	Drug Description
DB06674	Golimumab	A TNFα inhibitor used in the symptomatic treatment of various active inflammatory disorders, such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis.

Drug	Drug Name	Target	Type
DB06674	Golimumab	Tumor necrosis factor	target

Drug	Drug Name	Phase	Status	Count
DB01281	Abatacept	3	Completed	1